
Navidea Biopharmaceuticals Inc.
NAVB
NAVB: Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.
moreShow NAVB Financials
Recent trades of NAVB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NAVB's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on NAVB's company Twitter account
Number of mentions of NAVB in WallStreetBets Daily Discussion
Recent insights relating to NAVB
Recent picks made for NAVB stock on CNBC
ETFs with the largest estimated holdings in NAVB
Flights by private jets registered to NAVB